|
Galanina, Natalie; Goodman, Aaron M; Cohen, Philip R et al. (2018) Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade. Cancer Immunol Res 6:1129-1135
|
|
Goodman, Aaron M; Choi, Michael; Wieduwilt, Matthew et al. (2017) Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies. JCO Precis Oncol 1:
|
|
Busaidy, Naifa L; LoRusso, Patricia; Lawhorn, Kristie et al. (2015) The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab. Oncologist 20:737-41
|
|
Gonzalez-Angulo, Ana M; Krop, Ian; Akcakanat, Argun et al. (2015) SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. J Natl Cancer Inst 107:
|
|
Dasari, Arvind; Phan, Alexandria; Gupta, Sanjay et al. (2015) Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumors. Endocr Relat Cancer 22:431-41
|
|
Ganesan, Prasanth; Moulder, Stacy; Lee, J Jack et al. (2014) Triple-negative breast cancer patients treated at MD Anderson Cancer Center in phase I trials: improved outcomes with combination chemotherapy and targeted agents. Mol Cancer Ther 13:3175-84
|
|
Hong, David S; Garrido-Laguna, Ignacio; Ekmekcioglu, Suhendan et al. (2014) Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors. Cancer 120:2164-73
|
|
Liu, Xiaochun; Lorusso, Patricia; Mita, Monica et al. (2014) Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response. Oncologist 19:426-8
|
|
Abrams, Jeffrey S; Mooney, Margaret M; Zwiebel, James A et al. (2013) Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst 105:954-9
|
|
Ganesan, Prasanth; Janku, Filip; Naing, Aung et al. (2013) Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. Mol Cancer Ther 12:2857-63
|
Showing the most recent 10 out of 47 publications
